Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)

What is Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)?

Darunavir-cobicistat-tenofovir alafenamide-emtricitabine is a single-tablet regimen used in the treatment of HIV. It is a protease inhibitor (PI) based regimen with two nucleoside reverse transcriptase inhibitor (NRTI) and a booster.

Save up to 80% off your prescriptions!

How do members experience Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 2 1

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 1
Learn more about our community’s experience with Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)

What are people saying about Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)?

3

3

members have reported taking Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)

Join the conversation and connect with people who have taken Darunavir-cobicistat-tenofovir alafenamide-emtricitabine (DRV/c/TAF/FTC)
Last updated:

Save up to 80% off your prescriptions!

ADVERTISEMENT

ADVERTISEMENT